PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS

SOSMAN JA WEISS GR MARGOLIN KA ARONSON FR SZNOL M ATKINS MB OBOYLE K FISHER RI BOLDT DH DOROSHOW J ERNEST ML FISHER SG MIER J VACHINO G CALIENDO G

Ja. Sosman et al., PHASE-IB CLINICAL-TRIAL OF ANTI-CD3 FOLLOWED BY HIGH-DOSE BOLUS INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA AND ADVANCED RENAL-CELL CARCINOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS, Journal of clinical oncology, 11(8), 1993, pp. 1496-1505

60

Oncology

Journal of clinical oncology → ACNP

0732183X

11

8

1993

1496 - 1505

ISI

0732-183X(1993)11:8<1496:PCOAFB>2.0.ZU;2-F